Ruiz, Sitti Khadeejah .

HRN: 21-73-55  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/09/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/09/2022
08/16/2022
IV
300
Q6h
Laceration
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Non-compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: